Introduction Despite the availability of axial spondyloarthritis (SpA) recommendations
proposed by various rheumatology societies, we considered that a region‐specific guideline …

Objectives To update the Assessment of SpondyloArthritis international Society (ASAS)-
EULAR recommendations for the management of axial spondyloarthritis (axSpA). Methods …

Objective To provide evidence‐based recommendations for the treatment of patients with
ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA). Methods A …

To update and integrate the recommendations for ankylosing spondylitis and the
recommendations for the use of tumour necrosis factor inhibitors (TNFi) in axial …

Spondyloarthritis is a group of chronic inflammatory systemic diseases characterized by
axial and/or peripheral joints inflammation, as well as extra-articular manifestations. The …

Objective To update the evidence of non-biological treatments for axial spondyloarthritis
(axSpA), as a basis for the 2022 Assessment of SpondyloArthritis international Society …

Objective. The Canadian Rheumatology Association (CRA) and the Spondyloarthritis
Research Consortium of Canada (SPARCC) have collaborated to update the …

Spondyloarthritis (SpA) is the umbrella term for a broad spectrum of inflammatory rheumatic
diseases with typical but also rather different clinical manifestations, limited laboratory …

To assess the efficacy and safety of non-biological therapies in patients with axial
spondyloarthritis (axSpA) to inform the update of the Assessment of SpondyloArthritis …

Two main treatment targets in axial spondyloarthritis (axSpA) could be currently defined:(1)
reduction of inflammation resulting in control of signs and symptoms such as pain and …